Abstract
Outbreaks ofPneumocystispneumonia have been described in renal transplant recipients. Aerosolized pentamidine is frequently used for prophylaxis in this setting. We report our experience with aerosolized pentamidine use in 56 renal transplant recipients. We found high rates of adverse reactions in patients with chronic respiratory disease.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
MeSH terms
-
Adult
-
Aerosols
-
Antifungal Agents / administration & dosage
-
Antifungal Agents / adverse effects*
-
Bronchial Spasm / chemically induced
-
Bronchial Spasm / physiopathology
-
Female
-
Humans
-
Kidney Transplantation*
-
Lung / drug effects
-
Lung / physiopathology
-
Male
-
Pentamidine / administration & dosage
-
Pentamidine / adverse effects*
-
Pneumocystis / drug effects
-
Pneumocystis / physiology
-
Pneumonia, Pneumocystis / microbiology
-
Pneumonia, Pneumocystis / prevention & control*
-
Renal Insufficiency, Chronic / pathology
-
Renal Insufficiency, Chronic / surgery
-
Respiratory Tract Diseases / physiopathology*
-
Transplant Recipients
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*
Substances
-
Aerosols
-
Antifungal Agents
-
Pentamidine
-
Trimethoprim, Sulfamethoxazole Drug Combination